Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, acquired, eye disease characterized by progressive visual loss, due to bilateral juxtafoveolar capillary occlusions, capillary telangiectasia, and minimal exudation. It is associated with systemic or cerebral vascular occlusive disease.
Biomarker and diagnostic research for idiopathic macular telangiectasia type 3 has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for idiopathic macular telangiectasia type 3.
6 publications have been identified in PubMed for idiopathic macular telangiectasia type 3. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Diagnostic / Biomarker (17%).
Latalska M (2026). [PMID: 41682611](https://pubmed.ncbi.nlm.nih.gov/41682611/). *J Clin Med*. [Review / Meta-Analysis]
Carnevali A (2026). [PMID: 41420780](https://pubmed.ncbi.nlm.nih.gov/41420780/). *Graefes Arch Clin Exp Ophthalmol*. [Epidemiology / Natural History]
Forte P (2025). [PMID: 39824296](https://pubmed.ncbi.nlm.nih.gov/39824296/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Amoroso F (2024). [PMID: 38917396](https://pubmed.ncbi.nlm.nih.gov/38917396/). *Ophthalmic Surg Lasers Imaging Retina*. [Case Report / Case Series]
Mirescu AE (2024). [PMID: 39001242](https://pubmed.ncbi.nlm.nih.gov/39001242/). *Diagnostics (Basel)*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 3:44 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Kayabasi M (2024). [PMID: 39507809](https://pubmed.ncbi.nlm.nih.gov/39507809/). *Med Hypothesis Discov Innov Ophthalmol*. [Diagnostic / Biomarker]